Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 1Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Triple Negative Breast Neoplasms 1

Interventions

fludarabine 2Interleukin-2 2Cyclophosphamide 2toripalimab 1lenvatinib 1epigallocatechin gallate 1avelumab 1Zinc 1Tissue Banks 1Quercetin 1Pemetrexed 1Paclitaxel 1Optical Fibers 1Metformin 1Ethiodized Oil 1Docetaxel 1Dihematoporphyrin Ether 1Cisplatin 1Carboplatin 1Blood Specimen Collection 1Biopsy, Needle 1Bevacizumab 1Albumin-Bound Paclitaxel 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER_GOV × Zinc × Clear all
NCT05680662 2023-01-11

The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism

Ministry of Health, Saudi Arabia

Phase EARLY_PHASE1 Unknown
200 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡